1. Home
  2. PRSO vs BRTX Comparison

PRSO vs BRTX Comparison

Compare PRSO & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

N/A

Current Price

$1.43

Market Cap

7.8M

Sector

Technology

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

N/A

Current Price

$0.28

Market Cap

9.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRSO
BRTX
Founded
2008
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Managed Health Care
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
9.3M
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
PRSO
BRTX
Price
$1.43
$0.28
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
12.4M
7.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
86.27
66.08
EPS
N/A
N/A
Revenue
$14,573,000.00
$81,000.00
Revenue This Year
N/A
$24.64
Revenue Next Year
$35.76
$287.76
P/E Ratio
N/A
N/A
Revenue Growth
5.99
N/A
52 Week Low
$0.52
$0.19
52 Week High
$2.37
$2.10

Technical Indicators

Market Signals
Indicator
PRSO
BRTX
Relative Strength Index (RSI) 59.21 30.61
Support Level $1.38 $0.19
Resistance Level $1.59 $0.29
Average True Range (ATR) 0.13 0.03
MACD 0.08 0.04
Stochastic Oscillator 46.47 82.04

Price Performance

Historical Comparison
PRSO
BRTX

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: